Please provide your email address to receive an email when new articles are posted on . Once-monthly subcutaneous octreotide was associated with persistent control of IGF-I and growth hormone levels ...
An investigational treatment for acromegaly -- also known as gigantism -- was safe and boosted biochemical control, according to final topline findings of the phase III ACROINNOVA 2 study. Meeting the ...
Positive Results from MTD201-102 Study Support Subcutaneous Route for Long-Acting Octreotide Product ABINGDON, OXFORDSHIRE / ACCESSWIRE / January 8, 2020 / Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: ...
PARSIPPANY, N.J., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced today the launch of the first and only generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback